Company: MYSEW
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076607
Chunk: 40

Company: Myseum, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 40
---
 model with the following assumptions. The simplified
method was used for the expected option term and expected volatility was based on historical volatility:

     2025 
  
    Dividend rate 
     —%
  
    Term (in years) 
     3.5 to 6 years 
  
    Volatility 
     182.9% to 189.1%
  
    Risk—free interest rate 
     4.02% to 4.59%

The following is a summary of the Company’s
stock option activity for the six months ended June 30, 2025 as presented below:

     Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life (Years)   Balance on December 31, 2024   114,570   $126.92    2.08   Granted   325,000    5.20    -   Cancelled   (12,750)   (34.07)   -   Balance on June 30, 2025   426,820   $36.94    6.86   Options exercisable on June 30, 2025   106,820   $132.06    1.60   Weighted average fair value of options granted during the 2025 period       $4.30       

On June 30, 2025, the aggregate intrinsic value
of options outstanding was $0.

Common Stock Warrants

On January 16, 2024, in connection with the Underwriting
Agreement, the Company sold pre-funded warrants to purchase up to 590,000 shares of Common Stock (the “Pre-Funded Warrants”).
The public offering price was $1.8499 for each Pre-Funded Warrant for aggregate gross proceeds of $1,091,441. The per share exercise price
for the Pre-Funded Warrants was $0.0001 and the Pre-Funded Warrants were exercisable immediately. The Underwriters immediately exercised
the 590,000 Pre-Funded Warrants and the Underwriters received 589,981 shares of Common Stock since the exercise was cashless.

A summary of the Company’s outstanding stock
warrants, including 44,252 Series A public warrants, is presented below:

     Number of Warrants   Weighted Average